DE602006008964D1 - Verbindung eines beta3-rezeptor-agonisten mit monoamietzung damit und therapeutische verwendung dafür - Google Patents

Verbindung eines beta3-rezeptor-agonisten mit monoamietzung damit und therapeutische verwendung dafür

Info

Publication number
DE602006008964D1
DE602006008964D1 DE602006008964T DE602006008964T DE602006008964D1 DE 602006008964 D1 DE602006008964 D1 DE 602006008964D1 DE 602006008964 T DE602006008964 T DE 602006008964T DE 602006008964 T DE602006008964 T DE 602006008964T DE 602006008964 D1 DE602006008964 D1 DE 602006008964D1
Authority
DE
Germany
Prior art keywords
monoamination
therefor
connection
receptor agonist
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006008964T
Other languages
English (en)
Inventor
Guy Griebel
Jeanne Stemmelin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of DE602006008964D1 publication Critical patent/DE602006008964D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602006008964T 2005-09-19 2006-09-18 Verbindung eines beta3-rezeptor-agonisten mit monoamietzung damit und therapeutische verwendung dafür Active DE602006008964D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509528A FR2890862B1 (fr) 2005-09-19 2005-09-19 Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.
PCT/FR2006/002125 WO2007034056A1 (fr) 2005-09-19 2006-09-18 ASSOCIATION D'AGONISTE AUX RECEPTEURS ß3 ET D'INHIBITEURS DE LA RECAPTURE DE MONOAMINES, COMPOSITION PHARMACEUTIQUE LA CONTENANT ET SON UTILISATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
DE602006008964D1 true DE602006008964D1 (de) 2009-10-15

Family

ID=36384391

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006008964T Active DE602006008964D1 (de) 2005-09-19 2006-09-18 Verbindung eines beta3-rezeptor-agonisten mit monoamietzung damit und therapeutische verwendung dafür

Country Status (23)

Country Link
US (1) US20080182899A1 (de)
EP (1) EP1928448B1 (de)
JP (1) JP2009508829A (de)
KR (1) KR20080064115A (de)
CN (1) CN101267814A (de)
AR (1) AR055436A1 (de)
AT (1) ATE441407T1 (de)
AU (1) AU2006293801A1 (de)
BR (1) BRPI0616197A2 (de)
CA (1) CA2620235A1 (de)
CR (1) CR9768A (de)
DE (1) DE602006008964D1 (de)
EA (1) EA200800870A1 (de)
EC (1) ECSP088275A (de)
FR (1) FR2890862B1 (de)
IL (1) IL189755A0 (de)
MA (1) MA30002B1 (de)
NO (1) NO20081723L (de)
NZ (1) NZ566310A (de)
TN (1) TNSN08095A1 (de)
TW (1) TW200744571A (de)
WO (1) WO2007034056A1 (de)
ZA (1) ZA200802544B (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
US5288749A (en) * 1991-12-20 1994-02-22 Abbott Laboratories Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
US6288749B1 (en) * 1996-11-16 2001-09-11 Altec Lansing Technologies, Inc. Computer system with remote television display
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
KR20060087560A (ko) * 2003-09-12 2006-08-02 워너-램버트 캄파니 엘엘씨 알파-2-델타 리간드 및 ｓｓｒｉ 및/또는 ｓｎｒｉ를포함하는 우울증 및 불안 장애 치료용 조합물

Also Published As

Publication number Publication date
AR055436A1 (es) 2007-08-22
MA30002B1 (fr) 2008-12-01
CR9768A (es) 2008-09-23
BRPI0616197A2 (pt) 2011-06-14
FR2890862A1 (fr) 2007-03-23
ATE441407T1 (de) 2009-09-15
ECSP088275A (es) 2008-04-28
KR20080064115A (ko) 2008-07-08
FR2890862B1 (fr) 2008-01-25
US20080182899A1 (en) 2008-07-31
EP1928448A1 (de) 2008-06-11
TNSN08095A1 (en) 2009-07-14
NZ566310A (en) 2010-03-26
CN101267814A (zh) 2008-09-17
CA2620235A1 (fr) 2007-03-29
EA200800870A1 (ru) 2008-08-29
JP2009508829A (ja) 2009-03-05
IL189755A0 (en) 2008-12-29
NO20081723L (no) 2008-05-29
TW200744571A (en) 2007-12-16
ZA200802544B (en) 2009-08-26
EP1928448B1 (de) 2009-09-02
AU2006293801A1 (en) 2007-03-29
WO2007034056A1 (fr) 2007-03-29

Similar Documents

Publication Publication Date Title
DE602005003186D1 (de) Fluorkopolymer und dessen Verwendung
DE602005019173D1 (de) Ultraschallgerät und ultraschall-kontrollverfahren
DE602006012060D1 (de) Bicyclische bisamidderivate und deren anwendung als insektizide
DE602005011901D1 (de) Tragvorrichtung eines Computermonitors mit flachem Bildschirm
DK1844070T3 (da) Peptider med neuropeptid-2 receptor (Y2R) agonistaktivitet
DE602006012633D1 (de) Ausgleichsvorrichtung und Zylinderkopfanordnung
DK1780295T3 (da) Svejseforbindelse og svejsemateriale deraf
CR10779A (es) Agonist trkb antibodies and uses thereof
DE112009000348A5 (de) Anzeigefläche und damit kombinierte Steuervorrichtung
DE602006006684D1 (de) Flüssigkeits- und gasdichte röhrenförmige gewindeverbindung
DE602006015293D1 (de) 2-(4-oxo-4h-chinazolin-3-yl)acetamide und ihre verwendung als vasopressin-v3-antagonisten
DE602007003268D1 (de) Schiebeblende und Tonerzuführvorrichtung damit
DE502006007126D1 (de) Farbmesskopf und damit ausgestattete Abtastvorrichtung
DE602006018166D1 (de) Polyrotaxanhaltige lösung und verwendung davon
DE602006019861D1 (de) Säule und kassettensäule unter verwendung davon
DE602006021136D1 (de) Hülse und zylinderkopfabdeckung
DE602008001981D1 (de) Stellung und therapeutische verwendung
ATE420081T1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
DE602005016981D1 (de) Flüssigkeitstransportkopf und damit ausgestattetes Gerät
DE602007007792D1 (de) Zusammensetzung auf xanthoxylinbasis und kosmetische verwendung dafür
GB0513066D0 (en) Hinges and restricting devices therefor
DE602004011544D1 (de) Motorisierter und orientierbarer Messkopf
ATE555097T1 (de) 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente
ATE467621T1 (de) Cyclopropancarboxylate und deren verwendung als pestizide
DE602006005502D1 (de) Entwickler-regulierungsglied und entwicklungsvorrichtung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition